Tracing The Marketing of A Drug from $40 to $28,000 a Vial

Finding Profits, At $28,000 A Vial by Andrew Pollack.  The New York Times.  December 30, 2012.

In this discussion of the evolution of the  anti-inflammatory drug, H.P. Acthar Gel, from $40 to 28,000 a vial important issues are addressed including marketing practices, costs, insurance, orphan drugs, off-label prescriptions, efficacy research, drug licensing, and drug development.  A rich case study.